Journal of Substance Abuse Treatment
Volume 39, Issue 4 , Pages 378-383 , December 2010

Physician introduction to opioids for pain among patients with opioid dependence and depressive symptoms

  • Judith I. Tsui

      Affiliations

    • Boston University School of Medicine/Boston Medical Center, Boston MA 02118
    • Corresponding Author InformationCorresponding author. 801 Massachusetts Ave, Rm 2078, Boston, MA 02118. Tel.: +1 617 414 6912; fax: +1 617 414 4676.
    • ,
  • Debra S. Herman

      Affiliations

    • Butler Hospital, 345 Blackstone Blvd, Providence, RI 02906
    • Warren Alpert School of Medicine at Brown University, Providence, RI, 02912
    • ,
  • Malyna Kettavong

      Affiliations

    • Butler Hospital, 345 Blackstone Blvd, Providence, RI 02906
    • ,
  • Daniel Alford

      Affiliations

    • Boston University School of Medicine/Boston Medical Center, Boston MA 02118
    • ,
  • Bradley J. Anderson

      Affiliations

    • Butler Hospital, 345 Blackstone Blvd, Providence, RI 02906
    • ,
  • Michael D. Stein

      Affiliations

    • Butler Hospital, 345 Blackstone Blvd, Providence, RI 02906

Received 16 April 2010 ,Revised 25 June 2010 ,Accepted 25 June 2010.

References 

  1. MMWR . Adult use of prescription opioid pain medications—Utah, 2008. MMWR Morbidity and Mortal Weekly Report. 2010;59:153–157
  2. Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: A literature review. Archives of Internal Medicine. 2003;163:2433–2445
  3. Ballantyne JC, Mao J. Opioid therapy for chronic pain. New England Journal of Medicine. 2003;349:1943–1953
  4. Barkhuizen A, Rosen HR, Wolf S, Flora K, Benner K, Bennett RM. Musculoskeletal pain and fatigue are associated with chronic hepatitis C: A report of 239 hepatology clinic patients. American Journal of Gastroenterology. 1999;94:1355–1360
  5. Beck AT, Steer RA, Brown GK. Manual for the BDI-II. San Antonio, TX: The Psychological Corporation; 1996;
  6. Brands B, Blake J, Sproule B, Gourlay D, Busto U. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug and Alcohol Dependence. 2004;73:199–207
  7. Breitbart W, Rosenfeld BD, Passik SD, McDonald MV, Thaler H, Portenoy RK. The undertreatment of pain in ambulatory AIDS patients. Pain. 1996;65:243–249
  8. Brienza RS, Stein MD, Chen M, Gogineni A, Sobota M, Maksad J, et al. Depression among needle exchange program and methadone maintenance clients. Journal of Substance Abuse Treatment. 2000;18:331–337
  9. Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain. 2004;109:514–519
  10. Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: Molecular mechanisms and clinical considerations. Clinical Journal of Pain. 2008;24:479–496
  11. Croughan JL, Miller JP, Wagelin D, Whitman BY. Psychiatric illness in male and female narcotic addicts. Journal of Clinical Psychiatry. 1982;43:225–228
  12. Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002. Journal of Pain Symptom Management. 2004;28:176–188
  13. Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300:2613–2620
  14. Inciardi JA, Surratt HL, Cicero TJ, Beard RA. Prescription opioid abuse and diversion in an urban community: The results of an ultrarapid assessment. Pain Medicine. 2009;10:537–548
  15. Khantzian EJ, Treece C. DSM-III psychiatric diagnosis of narcotic addicts. Recent findings. Archive of General Psychiatry. 1985;42:1067–1071
  16. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The Fifth Edition of the Addiction Severity Index. Journal of Substance Abuse Treatment. 1992;9:199–213
  17. Melzack R. The short-form McGill Pain Questionnaire. Pain. 1987;30:191–197
  18. Miller I, Bishop S, Norman W, Maddever H. The Modified Hamilton Rating Scale for Depression: Reliability and validity. Psychiatry Research. 1985;14:131–142
  19. Olsen Y, Daumit GL, Ford DE. Opioid prescriptions by U.S. primary care physicians from 1992 to 2001. J Pain. 2006;7:225–235
  20. Passik SD. Issues in long-term opioid therapy: Unmet needs, risks, and solutions. Mayo Clin Proc. 2009;84:593–601
  21. Rosenblum A, Joseph H, Fong C, Kipnis S, Cleland C, Portenoy RK. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003;289:2370–2378
  22. Rosenblum A, Parrino M, Schnoll SH, Fong C, Maxwell C, Cleland CM, et al. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug and Alcohol Dependence. 2007;90:64–71
  23. Rounsaville BJ, Weissman MM, Crits-Christoph K, Wilber C, Kleber H. Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome. Archive of General Psychiatry. 1982;39:151–156
  24. Silberbogen AK, Janke EA, Hebenstreit C. A closer look at pain and hepatitis C: Preliminary data from a veteran population. Journal of Rehabilitation Research and Development. 2007;44:231–244
  25. Stanton L, McLeod C, Luckey B, Kissin WB, Sonnenfeld LJ. SAMHSA/CSAT Evaluation of the Buprenorphine Waiver Program. http://buprenorphine.samhsa.gov/ASAM_06_Final_Results.pdfaccessed 1/22/09
  26. Stein MD, Herman DS, Kettavong M, Cioe PA, Friedmann PD, Tellioglu T, et al. Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons. Journal of Substance Abuse Treatment. 2010;39:157–166
  27. Substance Abuse and Mental Health Services Administration . Results from the 2008 National Survey on Drug Use and Health: National Findings. In: Office of Applied Studies, NSDUH Series H-36, HHS Publication No. SMA 09-4434, Rockville, MD. 2009;
  28. Sullivan MD, Edlund MJ, Fan MY, Devries A, Brennan Braden J, Martin BC. Trends in use of opioids for non-cancer pain conditions 2000–2005 in commercial and Medicaid insurance plans: The TROUP study. Pain. 2008;138:440–449
  29. Thompson ME, Barkhuizen A. Fibromyalgia, hepatitis C infection, and the cytokine connection. Current Pain and Headache Report. 2003;7:342–347
  30. Ware JE, Kosinski M, Keller SD. A 12-item short form health survey: Construction of scales and preliminary tests of reliability and validity. Medical Care. 1996;34:220–233
  31. Warner M, Chen LH, Makuc DM. Increase in fatal poisonings involving opioid analgesics in the United States, 1999–2006. In: NCHS data brief(No. 22), Hyattsville, MD: National Center for Health Statistics. 2009. 2009;
  32. Wasan AD, Correll DJ, Kissin I, O'Shea S, Jamison RN. Iatrogenic addiction in patients treated for acute or subacute pain: A systematic review. Journal of Opioid Management. 2006;2:16–22
  33. Williams RE, Sampson TJ, Kalilani L, Wurzelmann JI, Janning SW. Epidemiology of opioid pharmacy claims in the United States. Journal of Opioid Management. 2008;4:145–152
  34. Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C. College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: Position statement. Drug and Alcohol Dependence. 2003;69:215–232

PII: S0740-5472(10)00154-6

doi: 10.1016/j.jsat.2010.06.012

Journal of Substance Abuse Treatment
Volume 39, Issue 4 , Pages 378-383 , December 2010

Article Tools

* Image Usage & Resolution